Regency Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,479
Closed -$3.94M 58
2023
Q4
$3.94M Sell
7,479
-1,002
-12% -$534K 2.65% 15
2023
Q3
$4.28M Sell
8,481
-3,191
-27% -$1.57M 3.63% 12
2023
Q2
$5.61M Buy
11,672
+3,051
+35% +$1.49M 4.88% 9
2023
Q1
$4.07M Buy
8,621
+3,270
+61% +$1.58M 4.93% 9
2022
Q4
$2.84M Sell
5,351
-66
-1% -$35K 3.26% 15
2022
Q3
$2.74M Sell
5,417
-874
-14% -$460K 3.35% 13
2022
Q2
$3.23M Buy
6,291
+614
+11% +$308K 3.48% 14
2022
Q1
$2.9M Sell
5,677
-41
-0.7% -$19.8K 2.1% 15
2021
Q4
$2.87M Buy
5,718
+653
+13% +$296K 1.82% 19
2021
Q3
$1.98M Buy
+5,065
New +$2.1M 1.39% 26

Other funds holding UNH

Regency Capital Management's UNH Position: Q1 2024 in Review

Regency Capital Management sold out of UnitedHealth (UNH) in Q1 2024, closing a stake of 7,479 shares — an estimated $3.94M sold.

Regency Capital Management first reported a position in UNH in Q3 2021 and held it in 10 quarters. The position peaked at $5.61M in Q2 2023. 3,375 funds tracked by Wall St. Rank hold UNH as of Q1 2024.

  • Regency Capital Management reported no remaining UnitedHealth position as of Q1 2024 after selling out during the quarter.
  • Regency Capital Management sold 7,479 UnitedHealth shares in Q1 2024, an estimated $3.94M.
  • Regency Capital Management first reported a position in UnitedHealth in Q3 2021 and held it in 10 quarters.
  • Regency Capital Management's UnitedHealth position peaked at $5.61M in Q2 2023.
  • 3,375 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2024.

Based on Regency Capital Management's 13F filing for Q1 2024, filed 7 May 2024.